naringenin has been researched along with kainic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Bae, YS; Jeong, KH; Jung, UJ; Kim, SR; Park, J; Shin, WH | 1 |
2 other study(ies) available for naringenin and kainic acid
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Naringenin ameliorates kainic acid-induced morphological alterations in the dentate gyrus in a mouse model of temporal lobe epilepsy.
Topics: Adaptor Proteins, Signal Transducing; Animals; Anticonvulsants; Carrier Proteins; Cell Cycle Proteins; Cytokines; Dentate Gyrus; Disease Models, Animal; Dose-Response Relationship, Drug; Epilepsy, Temporal Lobe; Eukaryotic Initiation Factors; Excitatory Amino Acid Agonists; Flavanones; Kainic Acid; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred C57BL; Microglia; Nerve Tissue Proteins; Phosphoproteins | 2016 |